Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Jumbodose has shown consistent performance in the New York market, particularly within the Tincture & Sublingual category. The brand has maintained a solid third-place ranking from March through June 2024, indicating strong consumer loyalty and effective market strategies. This stability in ranking is further supported by a noticeable upward trend in sales, with a significant increase from $67,646 in March to $95,976 in June. The consistent top-three ranking highlights Jumbodose’s strong foothold in the New York market for this category, suggesting that their product offerings resonate well with local consumers.
On the other hand, Jumbodose's performance across other states and categories is less consistent. In some regions, the brand did not make it into the top 30 rankings, indicating potential areas for improvement or increased competition. The absence of Jumbodose in the top rankings in these states could be seen as a negative indicator, suggesting that the brand might need to reassess its market strategies or product offerings to better compete. However, the strong performance in New York offers a blueprint that could be replicated in other markets, providing a pathway for potential growth and increased market share.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Jumbodose has consistently held the third rank from March 2024 to June 2024. This stability in ranking indicates a strong market presence, although it trails behind Head & Heal, which has maintained the top position, and Ayrloom, which is consistently second. While Jumbodose's sales have shown an upward trend, increasing from 67,646 in March to 95,976 in June, it still lags significantly behind Head & Heal, whose sales are more than double those of Jumbodose. Ayrloom also outpaces Jumbodose, with sales figures consistently higher each month. Meanwhile, OMO - Open Minded Organics and Canna Clinicals have not posed a significant threat, as they remain in the fourth and fifth positions respectively, with much lower sales. This competitive analysis highlights the need for Jumbodose to strategize on how to close the gap with the top two brands to improve its market share and sales performance.
Notable Products
In June 2024, the top-performing product for Jumbodose was the CBD/THC 5:1 Chill Tincture (1500mg CBD, 300mg THC, 30ml), maintaining its leading position with notable sales of 388 units. The Hybrid Mega Tincture (1000mg THC, 30ml) closely followed, ranking second and showing consistent performance from the previous month. The CBN/THC 5:1 Doze Tincture (1500mg CBN, 300mg THC, 30ml) rose to third place, a significant jump from its fourth position in the prior months. The CBG/THC 5:1 Focus Tincture (1500mg CBG, 300mg THC, 30ml) saw a slight decline, moving from third to fourth place. Lastly, the Rosin Drops Hash Tincture (300mg THC, 30ml) remained steady in fifth place, showing gradual sales improvement over the months.